Literature DB >> 1101670

Disposition of catecholamine-derived alkaloids in mammalian systems.

V E Davis, J L Cashaw, K D McMurtrey.   

Abstract

Tetrahydropapaveroline, the tetrahydroisoquinoline alkaloid derived from dopamine, is converted in vivo by rats and by rat liver and brain preparations to tetrahydroprotoberberine alkaloids. The latter alkaloids have also been identified for the first time in the urine of parkinsonian patients receiving L-dopa therapy. These findings suggest that man, like plants, may have the ability to elaborate several classes of alkaloids with potentially important pharmacological consequences. Thus, this newly demonstrated ability of mammalian systems to evoke the biosynthesis of benzyl-tetrahydroisoquinoline-derived alkaloids - a capability previously considered unique to plants - elects the tetrahydroprotoberberine alkaloids as representative of the first class of a possible constellation of complex mammalian alkaloids elaborated from the neuroamines.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1101670     DOI: 10.1007/978-1-4757-0632-1_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

1.  Possible mechanism of adverse reaction following levodopa plus benserazide treatment.

Authors:  F S Messiha
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

2.  Ethanol-induced changes in properties of rat brian ribosomes.

Authors:  S Tewari; F M Sweeney; E W Fleming
Journal:  Neurochem Res       Date:  1980-09       Impact factor: 3.996

Review 3.  Dopamine, morphine, and nitric oxide: an evolutionary signaling triad.

Authors:  George B Stefano; Richard M Kream
Journal:  CNS Neurosci Ther       Date:  2009-11-13       Impact factor: 5.243

Review 4.  Parkinson's disease, L-DOPA, and endogenous morphine: a revisit.

Authors:  George B Stefano; Kirk J Mantione; Milena Králíčková; Radek Ptacek; Hana Kuzelova; Tobias Esch; Richard M Kream
Journal:  Med Sci Monit       Date:  2012-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.